65,437 trials
Genital Herpes
Primary: Number of Participants With Solicited Local and Systemic ARs — 74; 75; 75; 74 Participants
Biphasic Mesothelioma · Epithelioid Mesothelioma · Peritoneal Malignant Mesothelioma
Primary: Ability of PD-L1 to Predict Response — 0.377 Youden index
Post-Resuscitation Syndrome · Critical Illness · Cardiac Arrest
Primary: 30-Day Mortality — 112 participants
Attention Deficit/Hyperactivity Disorder
Primary: Changes in Sleep Behavior — -6.5 percentage score change
Major Depressive Disorder
Primary: Incidence of Treatment Emergent Adverse Events — 23; 43 Participants
Elbow, Tennis
Primary: Change in Elbow Pain Using Visual Analog Scale (VAS) — 5.1; 3.0; 1.9; 1.1 VAS Score
Child Mental Health
Primary: NIH Toolbox Emotion Battery Test Anger Subscale Score — 49.8; 56.44; 52.19 T-score
Renal Disease, End Stage · Kidney Disease, End-Stage · AV Fistula
Primary: Cumulative Patency Through 12 Months Post-AVF Creation — 99.1 Probability as a percentage
Polycythemia Vera
Primary: Number of Participants With Adverse Events (AEs) — 20 Participants
Metastatic Malignant Neoplasm to Brain · Unspecified Adult Solid Tumor, Protocol Specific
Primary: Maximum Tolerated Dose (MTD) of Hypofractionated Radiosurgery Defined as the Highest Dose Level Where a Grade 3 or Greater With an Attribution Score of ≥ 3 Develops in ≤…
Uncomplicated Plasmodium Falciparum Malaria
Primary: Polymerase Chain Reaction (PCR)-Corrected Adequate Clinical and Parasitological Response (ACPR) - Cohorts 1 and 2 Pooled — 99.0; 99.0 Percentage of participants
Behavioral Shift (Researcher Willingness to Report-back)
Primary: Beliefs About Report-back, Before and After Training Program — 1.65; 1.91; 4.47; 4.62 Score on a scale
Homelessness · Youth
Primary: Feasibility and Acceptability of the Intervention Over 12 Months (Measured by Recruitment, Enrolment, and Dropout Metrics) — 20; 20; 18; 20 Participants
Asthma
Primary: Time to First Severe Asthma Exacerbation — NA; NA weeks
Ejaculation Delayed
Primary: To Determine the Effectiveness of Benzocaine of the Test Condom A Compared With the Control NRL Condom at Prolonging Time to Ejaculation — 168.40; 104.46 Seconds